On 21 August 2019, orphan designation EU/3/19/2200 was granted by the European Commission to Dr Sebastian Canisius, Germany, for clofazimine for the treatment of nontuberculous mycobacterial lung disease.
|Disease / condition||
Treatment of nontuberculous mycobacterial lung disease
|Date of first decision||
|EU designation number||
Review of designation
Sponsor's contact details
For contact details of patients’ organisations whose activities are targeted at rare diseases, see: